177 related articles for article (PubMed ID: 8596020)
1. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.
Nakano T; Ishii Y; Ishizaka K
J Immunol; 1996 Mar; 156(5):1728-34. PubMed ID: 8596020
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor.
Ishii Y; Nakano T; Ishizaka K
J Immunol; 1996 Mar; 156(5):1735-42. PubMed ID: 8596021
[TBL] [Abstract][Full Text] [Related]
3. Association of glycosylation-inhibiting factor with plasma membranes of T suppressor cell hybridomas.
Iwata M; Katamura K; Mori A; Yamagushi K; Grey H; Ishizaka K
J Immunol; 1990 Dec; 145(11):3578-88. PubMed ID: 2147196
[TBL] [Abstract][Full Text] [Related]
4. Relationship between T cell receptors and antigen-binding factors. I. Specificity of functional T cell receptors on mouse T cell hybridomas that produce antigen-binding T cell factors.
Iwata M; Katamura K; Kubo RT; Ishizaka K
J Immunol; 1989 Dec; 143(12):3909-16. PubMed ID: 2480378
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation-inhibiting factor from human T cell hybridomas constructed from peripheral blood lymphocytes of a bee venom-sensitive allergic patient.
Thomas P; Gomi H; Takeuchi T; Carini C; Tagaya Y; Ishizaka K
J Immunol; 1992 Feb; 148(3):729-37. PubMed ID: 1730869
[TBL] [Abstract][Full Text] [Related]
6. Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.
Iwata M; Ishizaka K
J Immunol; 1988 Nov; 141(10):3270-7. PubMed ID: 2460527
[TBL] [Abstract][Full Text] [Related]
7. Epitope specificity of bee venom phospholipase A2-specific suppressor T cells which produce antigen-binding glycosylation inhibiting factor.
Mori A; Thomas P; Tagaya Y; Iijima H; Grey H; Ishizaka K
Int Immunol; 1993 Aug; 5(8):833-42. PubMed ID: 7691164
[TBL] [Abstract][Full Text] [Related]
8. Relationship between T cell receptors and antigen-binding factors. II. Common antigenic determinants and epitope recognition shared by T cell receptors and antigen-binding factors.
Iwata M; Katamura K; Kubo RT; Grey HM; Ishizaka K
J Immunol; 1989 Dec; 143(12):3917-24. PubMed ID: 2480379
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal, antigen-specific, T cell contrasuppressor factor expresses determinants of TCR alpha-chain (not necessarily TCR beta-chain), having a molecular mass of about 40 kDa.
Paliwal V; Friedman AM; Ptak W; Askenase PW
J Immunol; 1994 Mar; 152(6):2811-20. PubMed ID: 7511628
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.
Watarai H; Nozawa R; Tokunaga A; Yuyama N; Tomas M; Hinohara A; Ishizaka K; Ishii Y
Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13251-6. PubMed ID: 11069294
[TBL] [Abstract][Full Text] [Related]
11. Transfection of TCR alpha-chains into suppressor and T helper cell hybridomas. Production of suppressor factors with predicted antigen specificity.
Kuchroo VK; Byrne MC; Greenfield E; Whitters MJ; Nalefsky EA; Rao A; Collins M; Dorf ME
J Immunol; 1995 May; 154(10):5030-8. PubMed ID: 7730610
[TBL] [Abstract][Full Text] [Related]
12. Requirement of certain epitope specificities of glycosylation inhibiting factor for the suppression of in vivo IgE and IgG antibody responses.
Yamaguchi K; Mori A; Ohno H; Tagaya Y; Ishizaka K
Int Immunol; 1992 Mar; 4(3):337-46. PubMed ID: 1373642
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.
Tomura T; Watarai H; Honma N; Sato M; Iwamatsu A; Kato Y; Kuroki R; Nakano T; Mikayama T; Ishizaka K
J Immunol; 1999 Jan; 162(1):195-202. PubMed ID: 9886386
[TBL] [Abstract][Full Text] [Related]
14. Antigen-binding glycosylation inhibiting factor from a human T-cell hybridoma specific for bee venom phospholipase A2.
Gomi H; Tagaya Y; Nakano T; Mikayama T; Ishizaka K
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2824-8. PubMed ID: 7511819
[TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.
Steele JK; Kuchroo VK; Kawasaki H; Jayaraman S; Iwata M; Ishizaka K; Dorf ME
J Immunol; 1989 Apr; 142(7):2213-20. PubMed ID: 2466892
[TBL] [Abstract][Full Text] [Related]
16. Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.
Ishii Y; Nakano T; Ishizaka K
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7207-12. PubMed ID: 8692970
[TBL] [Abstract][Full Text] [Related]
17. Expression of functional alpha beta T cell receptor gene rearrangements in suppressor T cell hybridomas correlates with antigen binding, but not with suppressor cell function.
Collins M; Kuchroo VK; Whitters MJ; O'Hara RM; Kelleher K; Kubo RT; Dorf ME
J Immunol; 1990 Nov; 145(9):2809-19. PubMed ID: 2170525
[TBL] [Abstract][Full Text] [Related]
18. Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.
Jardieu P; Akasaki M; Ishizaka K
J Immunol; 1987 Mar; 138(5):1494-501. PubMed ID: 3492554
[TBL] [Abstract][Full Text] [Related]
19. Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.
Nakano T; Liu YC; Mikayama T; Watarai H; Taniguchi M; Ishizaka K
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9196-200. PubMed ID: 7568100
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of glycosylation inhibiting factor on the IgE and IgG antibody response.
Akasaki M; Jardieu P; Ishizaka K
J Immunol; 1986 May; 136(9):3172-9. PubMed ID: 2937840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
